Company Profiles

driven by the PitchBook Platform

Adicet Bio

Adicet Bio
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
$51M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of next-generation cell immunotherapies designed to treat cancer. The company's next-generation cell immunotherapies are T-Cell Receptor like antibodies with high affinity and specificity to disease-specific intracellular peptides presented on the cell surface by the major histocompatibility complex, enabling physicians to identify and validate novel disease-specific peptide targets.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
200 Constitution Drive
Menlo Park, CA 94025
United States

+1 (310) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Adicet Bio’s full profile, request a free trial.

Adicet Bio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 27-Jan-2016 $51M 0000 0000 Completed Startup
1. Accelerator/Incubator 01-Sep-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Adicet Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.0 00.0 00.0 00 00.0 00.00
Series A-2 0,000,000 00.000000 00.0 00.0 00 00.0 0.000
Series A-1 629,633 $0.000100 $0.1 $1.2 $1.2 1x $1.2 0.85%
To view this company’s complete Cap Table, request access »

Adicet Bio Investments & Acquisitions (1)

Company Name Date Type Deal Size Industry Lead Partner
0000000 000000 000 27-Jan-2016 000000000000000000 Drug Discovery 000 0000000000 00.0
To view this company’s complete investment and acquisition history, request access »

Adicet Bio Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Novartis Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
OrbiMed Venture Capital Minority 000 0000 000000 0
Pontifax Venture Capital Venture Capital Minority 000 0000 000000 0
JLABS Accelerator/Incubator 000 0000 000000 0

Adicet Bio Executive Team (4)

Name Title Board
Seat
Contact
Info
Aya Jakobovits Ph.D Founder, Chief Executive Officer, President and Board Member
Anne Altmeyer Ph.D Chief Business Officer
Andy Lin Ph.D Vice President, Product Sciences

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

Adicet Bio Board Members (4)

Name Representing Role Since Contact
Info
Carl Gordon Adicet Bio Board Member 000 0000
Erez Chimovits OrbiMed Board Member 000 0000
Florent Gros Novartis Venture Fund Board Member 000 0000
Jonathan Silverstein Adicet Bio Board Member 000 0000
Questions or concerns about this profile? Reach out to website-support@pitchbook.com